Yes, there is an increase in AS cases following Covid. There is a high incidence of post-viral arthralgia; the covid virus is well-known for producing inflammatory markers in the body, and we are ...

Recordati today announces an agreement with Sanofi to acquire the global rights to Enjaymo® (sutimlimab), a biologic which is the only approved targeted product for the treatment of cold agglutinin ...

By Hugo Francisco de Souza As Oropouche virus cases rise across South America, experts call for urgent action to prevent its ...

Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major ...